CFTR c.3763T>C ;(p.S1255P)

Variant ID: 7-117282537-T-C

NM_000492.3(CFTR):c.3763T>C;(p.S1255P)

This variant was identified in 118 publications

View GRCh38 version.




Publications:


Dry Powder Inhalation for Lung Delivery in Cystic Fibrosis.

Pharmaceutics
Han, Xiaoxuan X; Li, Danni D; Reyes-Ortega, Felisa F; Schneider-Futschik, Elena K EK
Publication Date: 2023-05-13

Variant appearance in text: CFTR: S1255P
PubMed Link: 37242730
Variant Present in the following documents:
  • Main text
  • pharmaceutics-15-01488.pdf
View BVdb publication page



Network expansion of genetic associations defines a pleiotropy map of human cell biology.

Nature Genetics
Barrio-Hernandez, Inigo I; Schwartzentruber, Jeremy J; Shrivastava, Anjali A; Del-Toro, Noemi N; Gonzalez, Asier A; Zhang, Qian Q; Mountjoy, Edward E; Suveges, Daniel D; Ochoa, David D; Ghoussaini, Maya M; Bradley, Glyn G; Hermjakob, Henning H; Orchard, Sandra S; Dunham, Ian I; Anderson, Carl A CA; Porras, Pablo P; Beltrao, Pedro P
Publication Date: 2023-02-23

Variant appearance in text: CFTR: 3763T>C; Ser1255Pro
PubMed Link: 36823319
Variant Present in the following documents:
  • 41588_2023_1327_MOESM4_ESM.xlsx, sheet 6
View BVdb publication page



Organoid Technology and Its Role for Theratyping Applications in Cystic Fibrosis.

Children (Basel, Switzerland)
Conti, Jessica J; Sorio, Claudio C; Melotti, Paola P
Publication Date: 2022-12-20

Variant appearance in text: CFTR: S1255P
PubMed Link: 36670555
Variant Present in the following documents:
  • children-10-00004.pdf
View BVdb publication page



Role of inhaled antibiotics in the era of highly effective CFTR modulators.

European Respiratory Review : An Official Journal Of The European Respiratory Society
Elborn, J Stuart JS; Blasi, Francesco F; Burgel, Pierre-Régis PR; Peckham, Daniel D
Publication Date: 2023-03-31

Variant appearance in text: CFTR: S1255P
PubMed Link: 36631132
Variant Present in the following documents:
  • Main text
  • ERR-0154-2022.pdf
View BVdb publication page



The Exocrine Pancreas in Cystic Fibrosis in the Era of CFTR Modulation: A Mini Review.

Frontiers In Pediatrics
McKay, Isabelle R IR; Ooi, Chee Y CY
Publication Date: 2022

Variant appearance in text: CFTR: S1255P
PubMed Link: 35832587
Variant Present in the following documents:
  • Main text
  • fped-10-914790.pdf
View BVdb publication page



One Size Does Not Fit All: The Past, Present and Future of Cystic Fibrosis Causal Therapies.

Cells
Ensinck, Marjolein M MM; Carlon, Marianne S MS
Publication Date: 2022-06-08

Variant appearance in text: CFTR: 3763T>C; S1255P
PubMed Link: 35740997
Variant Present in the following documents:
  • Main text
  • cells-11-01868.pdf
View BVdb publication page



CFTR Modulators in People with Cystic Fibrosis: Real-World Evidence in France.

Cells
Regard, Lucile L; Martin, Clémence C; Burnet, Espérie E; Da Silva, Jennifer J; Burgel, Pierre-Régis PR
Publication Date: 2022-05-28

Variant appearance in text: CFTR: S1255P
PubMed Link: 35681464
Variant Present in the following documents:
  • cells-11-01769.pdf
View BVdb publication page



New drugs in cystic fibrosis: what has changed in the last decade?

Therapeutic Advances In Chronic Disease
Roda, Juliana J; Pinto-Silva, Catarina C; Silva, Iris A I IAI; Maia, Carla C; Almeida, Susana S; Ferreira, Ricardo R; Oliveira, Guiomar G
Publication Date: 2022

Variant appearance in text: CFTR: S1255P
PubMed Link: 35620188
Variant Present in the following documents:
  • Main text
  • 10.1177_20406223221098136.pdf
View BVdb publication page



Author Correction: Spatial covariance analysis reveals the residue-by-residue thermodynamic contribution of variation to the CFTR fold.

Communications Biology
Anglès, Frédéric F; Wang, Chao C; Balch, William E WE
Publication Date: 2022-05-18

Variant appearance in text: CFTR: S1255P
PubMed Link: 35585144
Variant Present in the following documents:
  • 42003_2022_3457_MOESM1_ESM.pdf
View BVdb publication page



The impact of FDA and EMA regulatory decision-making process on the access to CFTR modulators for the treatment of cystic fibrosis.

Orphanet Journal Of Rare Diseases
Costa, Enrico E; Girotti, Silvia S; Pauro, Francesca F; Leufkens, Hubert G M HGM; Cipolli, Marco M
Publication Date: 2022-05-07

Variant appearance in text: CFTR: S1255P
PubMed Link: 35525974
Variant Present in the following documents:
  • Main text
  • 13023_2022_Article_2350.pdf
View BVdb publication page



CFTR Modulator Therapies: Potential Impact on Airway Infections in Cystic Fibrosis.

Cells
Saluzzo, Francesca F; Riberi, Luca L; Messore, Barbara B; Loré, Nicola Ivan NI; Esposito, Irene I; Bignamini, Elisabetta E; De Rose, Virginia V
Publication Date: 2022-04-06

Variant appearance in text: CFTR: S1255P
PubMed Link: 35406809
Variant Present in the following documents:
  • cells-11-01243.pdf
View BVdb publication page



A Comparative Analysis of Pricing and Reimbursement of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Europe.

Frontiers In Pharmacology
Abdallah, Khadidja K; De Boeck, Kris K; Dooms, Marc M; Simoens, Steven S
Publication Date: 2021

Variant appearance in text: CFTR: S1255P
PubMed Link: 34858177
Variant Present in the following documents:
  • fphar-12-746710.pdf
View BVdb publication page



The determinants of survival among adults with cystic fibrosis-a cohort study.

Journal Of Physiological Anthropology
Durda-Masny, Magdalena M; Goździk-Spychalska, Joanna J; John, Aleksandra A; Czaiński, Wojciech W; Stróżewska, Weronika W; Pawłowska, Natalia N; Wlizło, Jolanta J; Batura-Gabryel, Halina H; Szwed, Anita A
Publication Date: 2021-11-08

Variant appearance in text: CFTR: S1255P
PubMed Link: 34749804
Variant Present in the following documents:
  • Main text
View BVdb publication page



Frequency of allele variations in the CFTR gene in a Mexican population.

Bmc Medical Genomics
Cantú-Reyna, Consuelo C; Galindo-Ramírez, Roberto R; Vázquez-Cantú, Mercedes M; Haddad-Talancón, Lorenza L; García-Muñoz, Willebaldo W
Publication Date: 2021-11-05

Variant appearance in text: rs121909041
PubMed Link: 34740355
Variant Present in the following documents:
  • 12920_2021_1111_MOESM1_ESM.xlsx, sheet 1
View BVdb publication page



State of the Art on Approved Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators and Triple-Combination Therapy.

Pharmaceuticals (Basel, Switzerland)
Meoli, Aniello A; Fainardi, Valentina V; Deolmi, Michela M; Chiopris, Giulia G; Marinelli, Francesca F; Caminiti, Caterina C; Esposito, Susanna S; Pisi, Giovanna G
Publication Date: 2021-09-15

Variant appearance in text: CFTR: S1255P
PubMed Link: 34577628
Variant Present in the following documents:
  • Main text
  • pharmaceuticals-14-00928.pdf
View BVdb publication page



Projecting the impact of triple CFTR modulator therapy on intravenous antibiotic requirements in cystic fibrosis using patient registry data combined with treatment effects from randomised trials.

Thorax
Keogh, Ruth H RH; Cosgriff, Rebecca R; Andrinopoulou, Eleni-Rosalina ER; Brownlee, Keith G KG; Carr, Siobhán B SB; Diaz-Ordaz, Karla K; Granger, Emily E; Jewell, Nicholas P NP; Lewin, Alex A; Leyrat, Clemence C; Schlüter, Daniela K DK; van Smeden, Maarten M; Szczesniak, Rhonda D RD; Connett, Gary J GJ
Publication Date: 2022-09

Variant appearance in text: CFTR: S1255P
PubMed Link: 34556554
Variant Present in the following documents:
  • thoraxjnl-2020-216265supp001.pdf
View BVdb publication page



Genomic stability at the coding regions of the multidrug transporter gene ABCB1: insights into the development of alternative drug resistance mechanisms in human leukemia cells.

Cancer Drug Resistance (Alhambra, Calif.)
Chen, Kevin G KG; Duran, George E GE; Mogul, Mark J MJ; Wang, Yan C YC; Ross, Kevin L KL; Jaffrézou, Jean-Pierre JP; Huff, Lyn M LM; Johnson, Kory R KR; Fojo, Tito T; Lacayo, Norman J NJ; Sikic, Branimir I BI
Publication Date: 2020

Variant appearance in text: rs121909041
PubMed Link: 34541464
Variant Present in the following documents:
  • cdr-3-959-SupplementaryMaterials.xlsx, sheet 4
View BVdb publication page



Efficacy of computational predictions of the functional effect of idiosyncratic pharmacogenetic variants.

Peerj
McConnell, Hannah H; Andrews, T Daniel TD; Field, Matt A MA
Publication Date: 2021

Variant appearance in text: rs121909041
PubMed Link: 34316407
Variant Present in the following documents:
  • Main text
View BVdb publication page



Anti-Inflammatory Influences of Cystic Fibrosis Transmembrane Conductance Regulator Drugs on Lung Inflammation in Cystic Fibrosis.

International Journal Of Molecular Sciences
Harwood, Kiera H KH; McQuade, Rachel M RM; Jarnicki, Andrew A; Schneider-Futschik, Elena K EK
Publication Date: 2021-07-16

Variant appearance in text: CFTR: S1255P
PubMed Link: 34299226
Variant Present in the following documents:
  • Main text
  • ijms-22-07606.pdf
View BVdb publication page



Cystic Fibrosis Human Organs-on-a-Chip.

Micromachines
Ogden, Herbert Luke HL; Kim, Hoyeol H; Wikenheiser-Brokamp, Kathryn A KA; Naren, Anjaparavanda P AP; Mun, Kyu Shik KS
Publication Date: 2021-06-25

Variant appearance in text: CFTR: S1255P
PubMed Link: 34202364
Variant Present in the following documents:
  • Main text
  • micromachines-12-00747.pdf
View BVdb publication page



New Therapies to Correct the Cystic Fibrosis Basic Defect.

International Journal Of Molecular Sciences
Bergeron, Christelle C; Cantin, André M AM
Publication Date: 2021-06-08

Variant appearance in text: CFTR: S1255P
PubMed Link: 34201249
Variant Present in the following documents:
  • Main text
View BVdb publication page



Real-World Long-Term Ivacaftor for Cystic Fibrosis in France: Clinical Effectiveness and Healthcare Resource Utilization.

Pulmonary Therapy
Hubert, Dominique D; Marguet, Christophe C; Benichou, Jacques J; DeSouza, Cynthia C; Payen-Champenois, Catherine C; Kinnman, Nils N; Chandarana, Keval K; Munck, Anne A; Fajac, Isabelle I; ,
Publication Date: 2021-12

Variant appearance in text: CFTR: S1255P
PubMed Link: 34101145
Variant Present in the following documents:
  • Main text
  • 41030_2021_Article_158.pdf
View BVdb publication page



Treatment of Pulmonary Disease of Cystic Fibrosis: A Comprehensive Review.

Antibiotics (Basel, Switzerland)
Girón Moreno, Rosa María RM; García-Clemente, Marta M; Diab-Cáceres, Layla L; Martínez-Vergara, Adrián A; Martínez-García, Miguel Ángel MÁ; Gómez-Punter, Rosa Mar RM
Publication Date: 2021-04-23

Variant appearance in text: CFTR: S1255P
PubMed Link: 33922413
Variant Present in the following documents:
  • Main text
View BVdb publication page



Identification of Potential Leukocyte Biomarkers Related to Drug Recovery of CFTR: Clinical Applications in Cystic Fibrosis.

International Journal Of Molecular Sciences
Pedrazzi, Marco M; Vercellone, Silvia S; Barberis, Elettra E; Capraro, Michela M; De Tullio, Roberta R; Cresta, Federico F; Casciaro, Rosaria R; Castellani, Carlo C; Patrone, Mauro M; Marengo, Emilio E; Lecca, Paola P; Melotti, Paola P; Sorio, Claudio C; Manfredi, Marcello M; Averna, Monica M
Publication Date: 2021-04-10

Variant appearance in text: CFTR: S1255P
PubMed Link: 33920274
Variant Present in the following documents:
  • Main text
View BVdb publication page



Actionable pharmacogenetic variants in Hong Kong Chinese exome sequencing data and projected prescription impact in the Hong Kong population.

Plos Genetics
Yu, Mullin Ho Chung MHC; Chan, Marcus Chun Yin MCY; Chung, Claudia Ching Yan CCY; Li, Andrew Wang Tat AWT; Yip, Chara Yin Wa CYW; Mak, Christopher Chun Yu CCY; Chau, Jeffrey Fong Ting JFT; Lee, Mianne M; Fung, Jasmine Lee Fong JLF; Tsang, Mandy Ho Yin MHY; Chan, Joshua Chun Ki JCK; Wong, Wilfred Hing Sang WHS; Yang, Jing J; Chui, William Chun Ming WCM; Chung, Patrick Ho Yu PHY; Yang, Wanling W; Lee, So Lun SL; Chan, Godfrey Chi Fung GCF; Tam, Paul Kwong Hang PKH; Lau, Yu Lung YL; Tang, Clara Sze Man CSM; Yeung, Kit San KS; Chung, Brian Hon Yin BHY
Publication Date: 2021-02

Variant appearance in text: CFTR: 3763T>C; rs121909041
PubMed Link: 33600428
Variant Present in the following documents:
  • pgen.1009323.s003.xlsx, sheet 1
View BVdb publication page



New Therapeutic Approaches in Cystic Fibrosis.

Turkish Journal Of Pharmaceutical Sciences
Fakıoğlu, Dolunay Merve DM; Altun, Beril B
Publication Date: 2020-12-23

Variant appearance in text: CFTR: S1255P
PubMed Link: 33389985
Variant Present in the following documents:
  • Main text
View BVdb publication page



Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del).

The Cochrane Database Of Systematic Reviews
Southern, Kevin W KW; Murphy, Jared J; Sinha, Ian P IP; Nevitt, Sarah J SJ
Publication Date: 2020-12-17

Variant appearance in text: CFTR: S1255P
PubMed Link: 33331662
Variant Present in the following documents:
  • Main text
View BVdb publication page



Novel therapeutic approaches for the management of cystic fibrosis.

Multidisciplinary Respiratory Medicine
Jaques, Ryan R; Shakeel, Arslan A; Hoyle, Cameron C
Publication Date: 2020-01-28

Variant appearance in text: CFTR: S1255P
PubMed Link: 33282281
Variant Present in the following documents:
  • Main text
  • mrm-15-1-690.pdf
View BVdb publication page



G970R-CFTR Mutation (c.2908G>C) Results Predominantly in a Splicing Defect.

Clinical And Translational Science
Fidler, Meredith C MC; Buckley, Alexandra A; Sullivan, James C JC; Statia, Marvin M; Boj, Sylvia F SF; Vries, Robert G J RGJ; Munck, Anne A; Higgins, Mark M; Moretto Zita, Matteo M; Negulescu, Paul P; van Goor, Fredrick F; De Boeck, Kris K
Publication Date: 2021-03

Variant appearance in text: CFTR: S1255P
PubMed Link: 33278322
Variant Present in the following documents:
  • Main text
View BVdb publication page



Current Treatment Options for Cystic Fibrosis-Related Liver Disease.

International Journal Of Molecular Sciences
Staufer, Katharina K
Publication Date: 2020-11-14

Variant appearance in text: CFTR: S1255P
PubMed Link: 33202578
Variant Present in the following documents:
  • Main text
  • ijms-21-08586.pdf
View BVdb publication page



Ivacaftor in Infants Aged 4 to <12 Months with Cystic Fibrosis and a Gating Mutation. Results of a Two-Part Phase 3 Clinical Trial.

American Journal Of Respiratory And Critical Care Medicine
Davies, Jane C JC; Wainwright, Claire E CE; Sawicki, Gregory S GS; Higgins, Mark N MN; Campbell, Daniel D; Harris, Christopher C; Panorchan, Paul P; Haseltine, Eric E; Tian, Simon S; Rosenfeld, Margaret M
Publication Date: 2021-03-01

Variant appearance in text: CFTR: S1255P
PubMed Link: 33023304
Variant Present in the following documents:
  • Main text
View BVdb publication page



Fluorescence assay for simultaneous quantification of CFTR ion-channel function and plasma membrane proximity.

The Journal Of Biological Chemistry
Prins, Stella S; Langron, Emily E; Hastings, Cato C; Hill, Emily J EJ; Stefan, Andra C AC; Griffin, Lewis D LD; Vergani, Paola P
Publication Date: 2020-12-04

Variant appearance in text: CFTR: S1255P
PubMed Link: 32934006
Variant Present in the following documents:
  • mmc1.pdf
View BVdb publication page



Single C-to-T substitution using engineered APOBEC3G-nCas9 base editors with minimum genome- and transcriptome-wide off-target effects.

Science Advances
Lee, Sangsin S; Ding, Ning N; Sun, Yidi Y; Yuan, Tanglong T; Li, Jing J; Yuan, Qichen Q; Liu, Lizhong L; Yang, Jie J; Wang, Qian Q; Kolomeisky, Anatoly B AB; Hilton, Isaac B IB; Zuo, Erwei E; Gao, Xue X
Publication Date: 2020-07

Variant appearance in text: CFTR: 3763T>C; Ser1255Pro
PubMed Link: 32832622
Variant Present in the following documents:
  • aba1773_Data_file_S1.xlsx, sheet 2
View BVdb publication page



Pharmacogenetics: An Important Part of Drug Development with A Focus on Its Application.

International Journal Of Biomedical Investigation
Oates, J T JT; Lopez, D D
Publication Date: 2018

Variant appearance in text: CFTR: S1255P
PubMed Link: 32467882
Variant Present in the following documents:
  • Main text
  • nihms-1581346.pdf
View BVdb publication page



Analysis of CFTR Mutation Spectrum in Ethnic Russian Cystic Fibrosis Patients.

Genes
Petrova, Nika V NV; Kashirskaya, Nataliya Y NY; Vasilyeva, Tatyana A TA; Kondratyeva, Elena I EI; Zhekaite, Elena K EK; Voronkova, Anna Y AY; Sherman, Victoria D VD; Galkina, Varvara A VA; Ginter, Eugeny K EK; Kutsev, Sergey I SI; Marakhonov, Andrey V AV; Zinchenko, Rena A RA
Publication Date: 2020-05-15

Variant appearance in text: CFTR: 3763T>C
PubMed Link: 32429104
Variant Present in the following documents:
  • Main text
View BVdb publication page



Transcriptomic and Proteostasis Networks of CFTR and the Development of Small Molecule Modulators for the Treatment of Cystic Fibrosis Lung Disease.

Genes
Strub, Matthew D MD; McCray, Paul B PB
Publication Date: 2020-05-13

Variant appearance in text: CFTR: S1255P
PubMed Link: 32414011
Variant Present in the following documents:
  • Main text
View BVdb publication page



.

Emc. Pediatria
Noël, S S; Sermet-Gaudelus, I I
Publication Date: 2020-03

Variant appearance in text: CFTR: S1255P
PubMed Link: 32288518
Variant Present in the following documents:
  • main.pdf
View BVdb publication page



Emerging Cystic Fibrosis Transmembrane Conductance Regulator Modulators as New Drugs for Cystic Fibrosis: A Portrait of in Vitro Pharmacology and Clinical Translation.

Acs Pharmacology & Translational Science
Ghelani, Drishti P DP; Schneider-Futschik, Elena K EK
Publication Date: 2020-02-14

Variant appearance in text: CFTR: S1255P
PubMed Link: 32259083
Variant Present in the following documents:
  • Main text
View BVdb publication page



CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine.

Frontiers In Pharmacology
Lopes-Pacheco, Miquéias M
Publication Date: 2019

Variant appearance in text: CFTR: S1255P
PubMed Link: 32153386
Variant Present in the following documents:
  • Main text
View BVdb publication page



Cost of precision medicine at a referral center for cystic fibrosis.

Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia
Marson, Fernando Augusto Lima FAL
Publication Date: 2020-03-02

Variant appearance in text: CFTR: S1255P
PubMed Link: 32130336
Variant Present in the following documents:
  • Main text
  • 1806-3713-jbpneu-46-02-e20190308.pdf
View BVdb publication page



Nanomedicine Approaches for the Pulmonary Treatment of Cystic Fibrosis.

Frontiers In Bioengineering And Biotechnology
Velino, Cecilia C; Carella, Francesca F; Adamiano, Alessio A; Sanguinetti, Maurizio M; Vitali, Alberto A; Catalucci, Daniele D; Bugli, Francesca F; Iafisco, Michele M
Publication Date: 2019

Variant appearance in text: CFTR: S1255P
PubMed Link: 31921811
Variant Present in the following documents:
  • Main text
View BVdb publication page



Ivacaftor for the Treatment of Cystic Fibrosis Coexisting with Trisomy 21: A Case Report.

Cureus
Charbek, Edward E; Kamel, Ghassan G; Nayak, Ravi P RP
Publication Date: 2019-11-18

Variant appearance in text: CFTR: S1255P
PubMed Link: 31890385
Variant Present in the following documents:
  • Main text
View BVdb publication page



Reimbursement Status and Recommendations Related to Orphan Drugs in European Countries.

Frontiers In Pharmacology
Stawowczyk, Ewa E; Malinowski, Krzysztof Piotr KP; Kawalec, Paweł P; Bobiński, Rafał R; Siwiec, Jacek J; Panteli, Dimitra D; Eckhardt, Helene H; Simoens, Steven S; Agusti, Antònia A; Dooms, Marc M; Pilc, Andrzej A
Publication Date: 2019

Variant appearance in text: CFTR: S1255P
PubMed Link: 31827433
Variant Present in the following documents:
  • Table_2.pdf
View BVdb publication page



Refinement of evolutionary medicine predictions based on clinical evidence for the manifestations of Mendelian diseases.

Scientific Reports
Šimčíková, Daniela D; Heneberg, Petr P
Publication Date: 2019-12-09

Variant appearance in text: CFTR: 3763T>C; S1255P
PubMed Link: 31819097
Variant Present in the following documents:
  • 41598_2019_54976_MOESM2_ESM.xlsx, sheet 9
View BVdb publication page



Cystic fibrosis precision therapeutics: Emerging considerations.

Pediatric Pulmonology
Joshi, Disha D; Ehrhardt, Annette A; Hong, Jeong S JS; Sorscher, Eric J EJ
Publication Date: 2019-11

Variant appearance in text: CFTR: S1255P
PubMed Link: 31715091
Variant Present in the following documents:
  • Main text
View BVdb publication page



Medical interventions for chronic rhinosinusitis in cystic fibrosis.

The Cochrane Database Of Systematic Reviews
Karanth, Tulasi Kota TK; Karanth, Veena Kota Laxminarayan Kl VKLK; Ward, Bryan K BK; Woodworth, Bradford A BA; Karanth, Laxminarayan L
Publication Date: 2019-10-23

Variant appearance in text: CFTR: S1255P
PubMed Link: 31642064
Variant Present in the following documents:
  • Main text
View BVdb publication page



REVEL and BayesDel outperform other in silico meta-predictors for clinical variant classification.

Scientific Reports
Tian, Yuan Y; Pesaran, Tina T; Chamberlin, Adam A; Fenwick, R Bryn RB; Li, Shuwei S; Gau, Chia-Ling CL; Chao, Elizabeth C EC; Lu, Hsiao-Mei HM; Black, Mary Helen MH; Qian, Dajun D
Publication Date: 2019-09-04

Variant appearance in text: CFTR: 3763T>C; S1255P
PubMed Link: 31484976
Variant Present in the following documents:
  • 41598_2019_49224_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page



The effect of CFTR modulators on a cystic fibrosis patient presenting with recurrent pancreatitis in the absence of respiratory symptoms: a case report.

Bmc Gastroenterology
Johns, J Dixon JD; Rowe, Steven M SM
Publication Date: 2019-07-11

Variant appearance in text: CFTR: S1255P
PubMed Link: 31296159
Variant Present in the following documents:
  • Main text
View BVdb publication page



Pharmacological analysis of CFTR variants of cystic fibrosis using stem cell-derived organoids.

Drug Discovery Today
Chen, Kevin G KG; Zhong, Pingyu P; Zheng, Wei W; Beekman, Jeffrey M JM
Publication Date: 2019-11

Variant appearance in text: CFTR: S1255P
PubMed Link: 31173911
Variant Present in the following documents:
  • Main text
View BVdb publication page



Cystic fibrosis revisited.

Journal Of Postgraduate Medicine
Kulkarni, H H; Kansra, S S; Karande, S S
Publication Date: 2019

Variant appearance in text: CFTR: S1255P
PubMed Link: 31169132
Variant Present in the following documents:
  • Main text
View BVdb publication page



An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2-5 years (KLIMB).

Journal Of Cystic Fibrosis : Official Journal Of The European Cystic Fibrosis Society
Rosenfeld, Margaret M; Cunningham, Steve S; Harris, William T WT; Lapey, Allen A; Regelmann, Warren E WE; Sawicki, Gregory S GS; Southern, Kevin W KW; Chilvers, Mark M; Higgins, Mark M; Tian, Simon S; Cooke, Jon J; Davies, Jane C JC; ,
Publication Date: 2019-11

Variant appearance in text: CFTR: S1255P
PubMed Link: 31053538
Variant Present in the following documents:
  • Main text
View BVdb publication page



Comparing access to orphan medicinal products in Europe.

Orphanet Journal Of Rare Diseases
Zamora, Bernarda B; Maignen, Francois F; O'Neill, Phill P; Mestre-Ferrandiz, Jorge J; Garau, Martina M
Publication Date: 2019-05-03

Variant appearance in text: CFTR: S1255P
PubMed Link: 31053154
Variant Present in the following documents:
  • 13023_2019_1078_MOESM1_ESM.xlsx, sheet 1
View BVdb publication page



Sequencing as a first-line methodology for cystic fibrosis carrier screening.

Genetics In Medicine : Official Journal Of The American College Of Medical Genetics
Beauchamp, Kyle A KA; Johansen Taber, Katherine A KA; Grauman, Peter V PV; Spurka, Lindsay L; Lim-Harashima, Jeraldine J; Svenson, Ashley A; Goldberg, James D JD; Muzzey, Dale D
Publication Date: 2019-11

Variant appearance in text: CFTR: 3763T>C; S1255P
PubMed Link: 31036917
Variant Present in the following documents:
  • 41436_2019_525_MOESM3_ESM.xlsx, sheet 1
View BVdb publication page



Secondary actionable findings identified by exome sequencing: expected impact on the organisation of care from the study of 700 consecutive tests.

European Journal Of Human Genetics : Ejhg
Thauvin-Robinet, Christel C; Thevenon, Julien J; Nambot, Sophie S; Delanne, Julian J; Kuentz, Paul P; Bruel, Ange-Line AL; Chassagne, Aline A; Cretin, Elodie E; Pelissier, Aurore A; Peyron, Chritine C; Gautier, Elodie E; Lehalle, Daphné D; Jean-Marçais, Nolwenn N; Callier, Patrick P; Mosca-Boidron, Anne-Laure AL; Vitobello, Antonio A; Sorlin, Arthur A; Tran Mau-Them, Frédéric F; Philippe, Christophe C; Vabres, Pierre P; Demougeot, Laurent L; Poé, Charlotte C; Jouan, Thibaud T; Chevarin, Martin M; Lefebvre, Mathilde M; Bardou, Marc M; Tisserant, Emilie E; Luu, Maxime M; Binquet, Christine C; Deleuze, Jean-François JF; Verstuyft, Céline C; Duffourd, Yannis Y; Faivre, Laurence L
Publication Date: 2019-08

Variant appearance in text: rs121909041
PubMed Link: 31019283
Variant Present in the following documents:
  • Main text
View BVdb publication page



Novel, rare and common pathogenic variants in the CFTR gene screened by high-throughput sequencing technology and predicted by in silico tools.

Scientific Reports
Pereira, Stéphanie Villa-Nova SV; Ribeiro, José Dirceu JD; Ribeiro, Antônio Fernando AF; Bertuzzo, Carmen Sílvia CS; Marson, Fernando Augusto Lima FAL
Publication Date: 2019-04-17

Variant appearance in text: CFTR: S1255P
PubMed Link: 30996306
Variant Present in the following documents:
  • Main text
  • 41598_2019_Article_42404.pdf
View BVdb publication page